Kodiak Sciences KOD
NASDAQ KOD
$35.36 -1.00 (-2.75%)
As of: Sep 4, 2026 · 3:59 PM EDT

Kodiak Sciences (KOD) Retained Earnings (2017 - 2026)

Kodiak Sciences' (KOD) quarterly Retained Earnings came in at -$1.6 billion in Q1 2026, down 16.64% YoY from -$1.9 billion in Q1 2025, and down 3.73% on a QoQ basis from -$1.6 billion in Q4 2025.

Analysis

Kodiak Sciences (KOD) Retained Earnings (2017 - 2026) Analysis & Trends

Kodiak Sciences (KOD) has 10 years of Retained Earnings data on file, last reported at -$1.6 billion in Q1 2026.

  • Quarterly Retained Earnings fell 16.64% year-over-year to -$1.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.6 billion (down 16.64% YoY) and the FY2025 annual result came in at -$1.6 billion, down 17.31% from the prior year.
  • Retained Earnings fell to -$1.6 billion in Q1 2026, from -$1.6 billion in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$1.3 million in Q4 2022 to a low of -$1.6 billion in Q1 2026.
  • A 5-year average of -$1.1 billion and a median of -$1.2 billion in 2024 frame the typical range for Retained Earnings.
  • Annual changes were most pronounced in 2022 — Retained Earnings slumped 3633022.22% — and 2024, when it fell 15.29%.
  • Tracing KOD's Retained Earnings over 5 years: stood at -$1.3 million in 2022, then slumped by 88081.41% to -$1.2 billion in 2023, then slipped by 15.29% to -$1.3 billion in 2024, then declined by 17.31% to -$1.6 billion in 2025, then dropped by 3.73% to -$1.6 billion in 2026.
  • The last three Retained Earnings figures came in at -$1.6 billion (Q1 2026), -$1.6 billion (Q4 2025), and -$1.5 billion (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Kodiak Sciences 2.21 Bn 2.21 Bn - -1.68 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.68 Bn
Mar 31, 2026 -1.62 Bn
Dec 31, 2025 -1.56 Bn
Sep 30, 2025 -1.50 Bn
Jun 30, 2025 -1.44 Bn
Mar 31, 2025 -1.39 Bn
Dec 31, 2024 -1.33 Bn
Sep 30, 2024 -1.28 Bn
Jun 30, 2024 -1.24 Bn
Mar 31, 2024 -1.20 Bn
Dec 31, 2023 -1.15 Bn
Sep 30, 2023 -1.09 Bn
Jun 30, 2023 -1.04 Bn
Mar 31, 2023 -962.82 Mn
Dec 31, 2022 -892.04 Mn
Sep 30, 2022 -821.59 Mn
Jun 30, 2022 -744.55 Mn
Mar 31, 2022 -653.93 Mn
Dec 31, 2021 -558.22 Mn
Sep 30, 2021 -465.05 Mn